What is Avicenna.AI?
Avicenna.AI specializes in developing advanced artificial intelligence solutions specifically for emergency radiology and the detection of incidental findings on CT scans. The company's technology automates repetitive tasks, enabling medical professionals to focus on critical cases and expedite diagnoses. This focus positions Avicenna.AI as a key player in enhancing diagnostic efficiency and accuracy within healthcare.
How much funding has Avicenna.AI raised?
Avicenna.AI has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2023): $10M with participation from Innovacom and CEMAG Invest
Key Investors in Avicenna.AI
Innovacom
Innovacom is a venture capital firm with a long history of investing in digital startups, including those in medical imaging and AI. Their participation suggests a strong belief in Avicenna.AI's technological potential and market strategy.
CEMAG Invest
Undisclosed investor participating in the funding round.
What's next for Avicenna.AI?
The recent major strategic investment signals a pivotal growth phase for Avicenna.AI, likely enabling further development of its AI platforms and expansion into new markets. This backing is expected to accelerate the company's mission to revolutionize emergency radiology through technological innovation, solidifying its position in the competitive health tech landscape.
See full Avicenna.AI company page
